Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06499519Completed

SpinChip Hs-cTnI Clinical Diagnostic Performance

Role: lead

NCT06463275Completed

SpinChip Hs-cTnI Determination of the 99th Percentile URL

Role: lead

NCT06851013Completed

SpinChip Hs-cTnI Multisite Precision

Role: lead

NCT06453707Completed

SpinChip Hs-cTnI Sample Type Validation

Role: lead

All 4 trials loaded